Skip to main content
. 2016 Jan 19;7(6):7343–7353. doi: 10.18632/oncotarget.6944

Figure 6. CXCR6-CXCL16 dependent adhesion of PCa cells with Human Bone marrow endothelial cells.

Figure 6

Untreated (Inline graphic), CXCL16 treated with (Inline graphic) or without CXCR6 blockade (Inline graphic) were incubated with DilC12 labeled human bone marrow endothelial cells (HBME) cells for 30 min. Attached cells were counted by measuring fluorescence of DilC12 (3) at 549/565nm (Ex/Em) after washing off the unattached HBME cells. Results are expressed as mean ± SE. Asterisk (*) indicates significant difference (p < 0.05) in PCa cell adhesion between treated and control cells.